Abbott’s blood tests can predict patient recovery from brain injury
Abbott's i-STAT TBI Plasma test and ARCHITECT core laboratory instrument were used to measure the two biomarkers.
News
Latest in
News
Paige and Sonora Quest to partner for pathology workflow digitalisation
Paige will provide Sonora Quest Laboratories with Paige Breast, Paige Prostate Detect and its FullFocus viewer.
University of Pennsylvania develops test for Covid-19 vaccine response
The test can be integrated into electronic health records to help clinicians counsel patients.
Empyrean and MD Anderson to advance radiation therapy technologies
Empyrean and MD Anderson will combine their expertise to improve radiation therapy delivery for cancer patients.
City of Hope researchers develop blood test to detect colorectal cancer
To better identify early-onset cancer, the researchers eliminated the miRNA markers shared by early-onset and late-onset patients.
HKU researchers develop wearable biosensing system
The new device can be integrated with a smartwatch and continuously monitors biosignals.
BD signs deal with Labcorp for companion diagnostics development
The companies will combine their capabilities to advance flow cytometry as an essential CDx modality for cancer.
Bodyport’s noninvasive biomarker platform secures FDA 510(k) clearance
The Bodyport Cardiac Scale allows individuals with fluid management conditions to monitor heart function and fluid status.